In a recent meeting, Food and Drug Administration directors discussed how emergency use authorizations (EUAs) affected the response to the COVID-19 pandemic. FDA officials also discussed possible changes to the EUA mechanism. “The flexibility of emergency use authorizations, and allowing the FDA […]
Employer Healthcare Costs Will Increase 5% in 2022 as the COVID-19 Pandemic Continues
A recent report released by Willis Towers Watson notes an expected 5% increase in healthcare costs in 2022. Premiums and employer premium contributions will rise, as will the costs of healthcare services. “Medical and pharmacy benefit costs are expected to increase by 5.2% next year, the report […]
ICER VP of Research Recognized as Emerging Health Leader, Seeks to Improve Health Equity
Foluso Agboola, a Nigerian researcher who pursued her training at Harvard before joining the Institute for Clinical and Economic Review (ICER), has been recognized by Managed Healthcare Executive as one of 13 rising stars. She’s passionate about drug pricing reform and addressing health […]
PRMA Consulting Senior Advisor Discusses the Four Pillars of Market Access and New Pharma Trends
Senior Advisor, Asia-Pacific at PRMA Consulting Jeff Weisel shared an update to his previous article detailing the four strategic pillars of market access. Major healthcare trends, such as expensive novel gene therapies, digital healthcare, and wearables have all changed the pharma landscape. At the […]
Part 2 of Aetion’s ICPE Research Spotlight Highlights RWD in COVID-19 Research and Updated RWE Guidance
According to Aetion, key highlights of the August ICPE All Access Meeting hosted by the International Society for Pharmacology (ISPE) include successfully using fit-for-purpose real world data (RWD) to understand the impact of COVID-19. Other major topics included comparisons between real world […]
Register Now for MAPS 2022 in New Orleans
The Medical Affairs Professional Society (MAPS) will host its next Global Annual Meeting in March 2022. The meeting will draw more than 500 medical affairs professionals and 120 speakers to a four-day conference in New Orleans, Louisiana. “Now is THE defining moment for Medical Affairs as we […]
Report on North America HEOR Market Forecast to 2027 Now Available
A new report discusses emerging and continuing trends in North America in health economics and outcomes research (HEOR). The report includes predictions until 2027, insight into the effects of COVID-19, and covers the growing use of real world evidence (RWE) and real world data (RWD). The market […]
PhRMA Seeks to Address Health Disparities and COVID-19 Impact, Awards $150,000 in Community-Level Grants
PhRMA has announced four health disparity initiatives that will receive a quarter of $150,000. The programs tackle COVID-19 vaccine hesitancy, improve access to vaccines and COVID-19 tests, and support pregnant women during and after pregnancy. “PhRMA recognizes the many interwoven factors that […]
Evidence Partners Highlights the Time-Saving Power of AI in COVID-19 Data Extraction Case Study
In a recently described case study, a health agency was able to cut costs by using the DistillerSR artificial intelligence (AI) data extraction tool. Evidence Partners reports that upon implementation of the automated data solution, investigators were able to spend more time on critical COVID-19 […]
PhRMA’s 2021 Biopharmaceutical Industry Profile Now Available
PhRMA has published this year’s Biopharmaceutical Profile. The report highlights key industry trends, such as prescription drug pricing policy measures, product access challenges, pharmaceutical innovation, and the impact of COVID-19. “The Profile has told the story of the biopharmaceutical […]
